Editorial
Accepted on 16 Jul 2024
Editorial: Case Reports in Frontiers in Gastroenterology
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1458278
Type at least 3 characters
23 articles
Articles
Original Research
Accepted on 12 Jul 2024
Awareness and Acceptability of Gut Microbiome Transfer
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1411898
Original Research
Published on 13 Jun 2024
The effect of Smoking in Inflammatory Bowel Disease Outcomes
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1395269
- 357 views
Perspective
Published on 03 Jun 2024
The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1335380
- 448 views
Original Research
Published on 28 May 2024
Efficacy of oral viscous budesonide to reduce dilation treatment after esophageal atresia repair: a retrospective study
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1404292
- 318 views
Review
Published on 02 May 2024
Stress reduction and psychological therapy for IBS: a scoping review
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1342888
- 534 views
Original Research
Published on 18 Mar 2024
Spring-mediated distraction enterogenesis may alter the course of adaptation in porcine short bowel syndrome
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2024.1292226
- 659 views
Original Research
Published on 24 Jan 2024
Intensified anti-TNF treatment downregulates the phenotype in ulcerative colitis: a 13-year prospective follow-up study
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1304944
- 381 views
Original Research
Published on 04 Jan 2024
Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1296048
- 3,225 views
- 1 citation
Review
Published on 07 Nov 2023
Current status and clinical applications of tissue engineering of the gastrointestinal tract: a systematized narrative review
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1277094
- 1,002 views
Original Research
Published on 23 Oct 2023
Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1218228
- 570 views
- 1 citation
Original Research
Published on 18 Oct 2023
A blood-based transcriptomic signature stratifies severe Crohn’s disease and defines potentially targetable therapeutic pathways
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1251133
- 843 views
Review
Published on 03 Oct 2023
Sex- and gender-related differences in inflammatory bowel diseases
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1199687
- 8,022 views
- 1 citation
Mini Review
Published on 09 Aug 2023
Molecular medicine-based IBD treatment strategies—we take it personally!
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1226048
- 941 views
Brief Research Report
Published on 26 Jul 2023
A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1162109
- 1,763 views
Review
Published on 25 May 2023
Monitoring of patients with active inflammatory bowel disease
in Therapy in Gastroenterology
Frontiers in Gastroenterology
doi 10.3389/fgstr.2023.1172318
- 3,890 views
- 4 citations